Biogen Says Another Falls Ill After Taking MS Drug
For the third time since reintroducing the treatment to the market, Biogen Idec Inc. has said that a multiple sclerosis patient treated with its drug Tysabri has developed a rare but...To view the full article, register now.
Already a subscriber? Click here to view full article